Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
What Is The Future Market Size Estimation For The Pneumothorax Treatment Devices Market Covering 2025–2034?
The valuation of the market encompassing devices utilized for treating pneumothorax has demonstrated robust expansion over the preceding years, projected to move from a figure of $3.62 billion in the year 2024 to $3.98 billion by 2025, reflecting an annualized growth rate, or CAGR, of 10.0%. This upward trajectory observed during the retrospective period is largely attributable to several contributing factors, including the escalating frequency of pneumothorax occurrences, heightened general knowledge regarding the condition, expansions within emergency and trauma treatment infrastructure, the demographic shift toward an older populace, and an increase in the volume of surgical interventions performed.
The market valuation for pneumothorax treatment apparatus is projected to experience swift expansion over the ensuing timeframe, culminating in a figure of $5.86 billion by the year 2029, reflecting a compound annual growth rate (CAGR) of 10.1%. This anticipated surge during the forecasting interval stems from several key factors, such as the increasing incidence of pulmonary illnesses, a greater volume of chest operations being performed, augmented capital allocation toward medical facilities, enhancements in the ability to diagnose conditions, and a stronger emphasis on proactive health measures. Significant ongoing developments within this sector encompass the evolution of medical equipment technology itself, the emergence of sophisticated chest drainage setups, the introduction of automated thoracic tubing, progress in surgical techniques that minimize invasiveness, and the incorporation of remote health monitoring capabilities via telemedicine.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20929&type=smp
Which Major Market Drivers Are Shaping The Future Of The Pneumothorax Treatment Devices Market?
A surge in respiratory ailments is anticipated to serve as a key catalyst for the expansion of the market for pneumothorax treatment apparatus. These medical conditions impact the pulmonary system and air passages, thereby hindering respiration and the vital exchange of oxygen. Elevated instances of respiratory diseases stem from various contributors, including atmospheric contamination, tobacco use, infectious viral agents, and greater exposure to allergenic substances. Devices employed in pneumothorax management are utilized within the context of respiratory illnesses to address lung collapse scenarios and re-establish typical respiratory performance. To illustrate this trend, figures released in June 2024 by the American Lung Association, a non-profit entity situated in the U.S., indicated that roughly 44.2 million individuals across the United States, representing 13.5 percent of the entire populace, had been diagnosed with asthma by a certified healthcare provider in the year 2022. Consequently, the escalating prevalence of respiratory diseases directly fuels the advancement of the market focused on devices for treating pneumothorax.
What Are The Major Segment Categories Driving The Pneumothorax Treatment Devices Market Growth?
The pneumothorax treatment devicesmarket covered in this report is segmented –
1) By Type: Ventilator Devices, Thoracic Vent Devices, Other Types
2) By Application: Traumatic Pneumothorax, Spontaneous Pneumothorax, Other Applications
3) By End-User: Hospitals, Ambulatory Surgical Centers, Other End Users
Subsegments:
1) By Ventilator Devices: Portable Ventilators, Non-Invasive Ventilators, Invasive Ventilators
2) By Thoracic Vent Devices: Chest Drainage Systems, Heimlich Valves, One-Way Chest Valve Systems
3) By Other Types: Needle Aspiration Devices, Pleural Catheters, Oxygen Therapy Devices
What Are The Major Trends Driving The Growth Of The Pneumothorax Treatment Devices Market?
Leading corporations within the pneumothorax treatment devices sector are heavily invested in pioneering sophisticated technological offerings, exemplified by advancements in chest X-ray modalities, as a strategy to maintain their competitive standing. Chest X-ray solutions encompass a suite of imaging apparatuses, machinery, and related methodologies engineered to procure high-fidelity pictures of thoracic anatomy, encompassing the pulmonary system, cardiac organ, osseous framework, and adjacent tissues. As an illustration, a significant development occurred in September 2023 when Qure.ai, an American healthcare technology firm, successfully obtained 510(k) authorization from the FDA for its novel chest X-ray application, named qXR-PTX-PE. This specific tool is engineered to facilitate the swift identification of both pneumothorax (PTX) and pleural effusion (PE). Incorporating artificial intelligence, this software improves clinical workflows in critical care environments such as ICUs and ERs by promptly alerting medical personnel to necessary actions. The qXR-PTX-PE system examines radiographic images of the chest for urgent abnormalities, thereby markedly boosting the speed of patient sorting in emergency departments, a scenario where timely diagnosis of these ailments is paramount for patient well-being.
Who Are The Major Companies Operating In The Pneumothorax Treatment Devices Market?
Major companies operating in the pneumothorax treatment devices market are Cardinal Health Inc., Medtronic PLC, Siemens Healthineers AG, Medline Industries Inc., Fujifilm Holdings Corporation, Becton Dickinson and Company (BD), GE HealthCare Technologies Inc., Stryker Corporation, Boston Scientific Corporation, Draegerwerk AG & Co. KGaA, Cook Medical Inc., B. Braun Melsungen AG, Utah Medical Products Inc., Rocket Medical plc, Nobelpharma Co. Ltd., Sinapi Biomedical Inc., UreSil Inc., ATMOS MedizinTechnik GmbH & Co. KG, Betaglue Technologies S.p.A., Selio Medical Inc.
Download The Full Report For Exclusive Market Findings:
How Does The Pneumothorax Treatment Devices Market Perform Across Key Geographic Regions?
North America was the largest region in the pneumothorax treatment devices market in 2024. The regions covered in the pneumothorax treatment devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Pneumothorax Treatment Devices Market Report:
https://www.thebusinessresearchcompany.com/customise?id=20929&type=smp
Browse Through More Reports Similar to the Global Pneumothorax Treatment Devices Market 2025, By The Business Research Company
Fertility Treatments Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/fertility-treatments-global-market-report
Polycystic Ovarian Syndrome Treatment Global Market Report 2025
Alzheimer Disease Treatment Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/alzheimer-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model